Cargando…
Effects of the Addition of Hiltonol(®) (Poly-ICLC) to a SARS-CoV S Protein Vaccine in Lethal SARS-CoV Mouse Model
Autores principales: | Barnard, Dale L., Wandersee, Miles, Bailey, Kevin, Smith, Aaron, Vest, Zach, Morrey, John D., Salazar, Andres M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V.
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7133864/ http://dx.doi.org/10.1016/j.antiviral.2011.03.022 |
Ejemplares similares
-
Prophylactic and therapeutic intranasal administration with an immunomodulator, Hiltonol(®) (Poly IC:LC), in a lethal SARS-CoV-infected BALB/c mouse model
por: Kumaki, Yohichi, et al.
Publicado: (2017) -
Evaluation of Interferon Inducers, Ribavirin and Mouse Hyperimmune Serum in a Pathogenesis/Lethal Mouse Model Using a Mouse-adapted SARS-CoV
por: Barnard, Dale, et al.
Publicado: (2008) -
Prophylactic Efficacy of Intranasally Administered HSP Nanoparticles for Treating a Lethal SARS-CoV Infection in BALB/c Mice
por: Barnard, Dale, et al.
Publicado: (2009) -
Inhibition of severe acute respiratory syndrome coronavirus replication in a lethal SARS-CoV BALB/c mouse model by stinging nettle lectin, Urtica dioica agglutinin
por: Kumaki, Yohichi, et al.
Publicado: (2011) -
Single-dose intranasal administration with mDEF201 (adenovirus vectored mouse interferon-alpha) confers protection from mortality in a lethal SARS-CoV BALB/c mouse model
por: Kumaki, Yohichi, et al.
Publicado: (2011)